Results 1 - 20 of 605 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Refined by:
Journal Title:
American Journal Of Ophthalmology
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Intravitreal Aflibercept Injection for Macular Edema Secondary to Central Retinal Vein Occlusion: 1-Year Results From the Phase 3 COPERNICUS StudyAmerican journal of ophthalmology, 2013-03, Vol.155 (3), p.429-437.e7 [Peer Reviewed Journal]Elsevier Inc. ;2013 Elsevier Inc. ;Copyright © 2013 Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2012.09.026 ;PMID: 23218699 ;CODEN: AJOPAAFull text available |
| 2 |
Material Type: Article
|
|
Biosimilars for Retinal Diseases: An UpdateAmerican journal of ophthalmology, 2021-04, Vol.224, p.36-42 [Peer Reviewed Journal]2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Elsevier Inc. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2020.11.017 ;PMID: 33309691Full text available |
| 3 |
Material Type: Article
|
|
Optical Coherence Tomography Angiography of Type 1 Neovascularization in Age-Related Macular DegenerationAmerican journal of ophthalmology, 2015-10, Vol.160 (4), p.739-748.e2 [Peer Reviewed Journal]Elsevier Inc. ;2015 Elsevier Inc. ;Copyright © 2015 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Oct 2015 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2015.06.030 ;PMID: 26164826 ;CODEN: AJOPAAFull text available |
| 4 |
Material Type: Article
|
|
Cost-Utility Analysis of VEGF Inhibitors for Treating Neovascular Age-Related Macular DegenerationAmerican journal of ophthalmology, 2020-10, Vol.218, p.225-241 [Peer Reviewed Journal]2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Elsevier Inc. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2020.05.029 ;PMID: 32565050Full text available |
| 5 |
Material Type: Article
|
|
Short-Term Outcomes of Aflibercept for Neovascular Age-Related Macular Degeneration in Eyes Previously Treated With Other Vascular Endothelial Growth Factor InhibitorsAmerican journal of ophthalmology, 2013-07, Vol.156 (1), p.23-28.e2 [Peer Reviewed Journal]2013 ;Published by Elsevier Inc. ;Copyright Elsevier Limited Jul 2013 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2013.02.009 ;PMID: 23664153 ;CODEN: AJOPAAFull text available |
| 6 |
Material Type: Article
|
|
Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy: Two-Year Results of the Aflibercept in Polypoidal Choroidal Vasculopathy StudyAmerican journal of ophthalmology, 2019-08, Vol.204, p.80-89 [Peer Reviewed Journal]2019 ;Copyright © 2019. Published by Elsevier Inc. ;Copyright Elsevier Limited Aug 2019 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2019.02.027 ;PMID: 30849345Full text available |
| 7 |
Material Type: Article
|
|
Serum and Plasma Vascular Endothelial Growth Factor Concentrations Before and After Intravitreal Injection of Aflibercept or Ranibizumab for Age-Related Macular DegenerationAmerican journal of ophthalmology, 2014-10, Vol.158 (4), p.738-744.e1 [Peer Reviewed Journal]Elsevier Inc. ;2014 Elsevier Inc. ;Copyright © 2014 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Oct 2014 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2014.06.009 ;PMID: 24973606 ;CODEN: AJOPAAFull text available |
| 8 |
Material Type: Article
|
|
Serum Concentrations of Bevacizumab (Avastin) and Vascular Endothelial Growth Factor in Infants With Retinopathy of PrematurityAmerican journal of ophthalmology, 2012-02, Vol.153 (2), p.327-333.e1 [Peer Reviewed Journal]Elsevier Inc. ;2012 Elsevier Inc. ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2011.07.005 ;PMID: 21930258 ;CODEN: AJOPAAFull text available |
| 9 |
Material Type: Article
|
|
Early Response to Anti–Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol TAmerican journal of ophthalmology, 2018-11, Vol.195, p.93-100 [Peer Reviewed Journal]2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;COPYRIGHT 2018 Elsevier B.V. ;Copyright Elsevier Limited Nov 2018 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2018.07.030 ;PMID: 30077569Full text available |
| 10 |
Material Type: Article
|
|
Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and RanibizumabAmerican journal of ophthalmology, 2013-07, Vol.156 (1), p.15-22.e1 [Peer Reviewed Journal]Elsevier Inc. ;2013 Elsevier Inc. ;Copyright © 2013 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jul 2013 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2013.02.017 ;PMID: 23706500 ;CODEN: AJOPAAFull text available |
| 11 |
Material Type: Article
|
|
Suppression of Intraocular Vascular Endothelial Growth Factor During Aflibercept Treatment of Age-Related Macular DegenerationAmerican journal of ophthalmology, 2014-09, Vol.158 (3), p.532-536 [Peer Reviewed Journal]Elsevier Inc. ;2014 Elsevier Inc. ;Copyright © 2014 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Sep 2014 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2014.05.025 ;PMID: 24879948 ;CODEN: AJOPAAFull text available |
| 12 |
Material Type: Article
|
|
KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular EdemaAmerican journal of ophthalmology, 2022-06, Vol.238, p.157-172 [Peer Reviewed Journal]2022 ;Copyright © 2022. Published by Elsevier Inc. ;Copyright Elsevier Limited Jun 2022 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2022.01.004 ;PMID: 35038415Full text available |
| 13 |
Material Type: Article
|
|
Systemic Arterial and Venous Thrombotic Events Associated With Anti–Vascular Endothelial Growth Factor Injections: A Meta-AnalysisAmerican journal of ophthalmology, 2024-06, Vol.262, p.86-96 [Peer Reviewed Journal]2024 Elsevier Inc. ;Copyright © 2024 Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2024.01.016 ;PMID: 38244962Full text available |
| 14 |
Material Type: Article
|
|
Early Residual Fluid-Free Status and Long-Term BCVA Outcomes: A Treatment Agnostic, Post Hoc Analysis of Pooled HAWK and HARRIER DataAmerican journal of ophthalmology, 2022-04, Vol.236, p.12-19 [Peer Reviewed Journal]2021 The Authors ;Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. ;2021. The Authors ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2021.10.017 ;PMID: 34695400Full text available |
| 15 |
Material Type: Article
|
|
Conversion to Aflibercept For Chronic Refractory Or Recurrent Neovascular Age-Related Macular DegenerationAmerican journal of ophthalmology, 2013-07, Vol.156 (1), p.29-35.e2 [Peer Reviewed Journal]Elsevier Inc. ;2013 Elsevier Inc. ;Copyright © 2013 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jul 2013 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2013.03.030 ;PMID: 23668679 ;CODEN: AJOPAAFull text available |
| 16 |
Material Type: Article
|
|
Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and AfliberceptAmerican journal of ophthalmology, 2016-05, Vol.165, p.88-93 [Peer Reviewed Journal]2016 Elsevier Inc. ;Copyright © 2016 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited May 2016 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2016.02.028 ;PMID: 26944277 ;CODEN: AJOPAAFull text available |
| 17 |
Material Type: Article
|
|
Treat and extend therapy using aflibercept for neovascular age-related macular degeneration: a prospective clinical trialAmerican journal of ophthalmology, 2017-08, Vol.180, p.142-150 [Peer Reviewed Journal]Elsevier Inc. ;2017 Elsevier Inc. ;Copyright © 2017 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Aug 1, 2017 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2017.06.002 ;PMID: 28624325Full text available |
| 18 |
Material Type: Article
|
|
Month 60 Outcomes After Treatment Initiation With Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein OcclusionAmerican journal of ophthalmology, 2022-08, Vol.240, p.330-341 [Peer Reviewed Journal]2022 Elsevier Inc. ;Copyright © 2022 Elsevier Inc. All rights reserved. ;2022. Elsevier Inc. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2022.04.001 ;PMID: 35461831Full text available |
| 19 |
Material Type: Article
|
|
Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX StudyAmerican journal of ophthalmology, 2019-01, Vol.197, p.156-167 [Peer Reviewed Journal]2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jan 2019 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2018.08.026 ;PMID: 30148987Full text available |
| 20 |
Material Type: Article
|
|
One-Year Result of Aflibercept Treatment on Age-Related Macular Degeneration and Predictive Factors for Visual OutcomeAmerican journal of ophthalmology, 2015-05, Vol.159 (5), p.853-860.e1 [Peer Reviewed Journal]Elsevier Inc. ;2015 Elsevier Inc. ;Copyright © 2015 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited May 2015 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2015.01.018 ;PMID: 25634529 ;CODEN: AJOPAAFull text available |
Results 1 - 20 of 605 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Refine My Results
Creation Date
- Before 2005 (16)
- 2005 To 2009 (128)
- 2010 To 2014 (173)
- 2015 To 2020 (222)
- After 2020 (67)
-
More options
Resource Type
- Articles (603)
- Reviews (2)
-
More options
Subject
- Ophthalmology (555)
- Life Sciences & Biomedicine (538)
- Science & Technology (538)
- Humans (522)
- Vascular Endothelial Growth Factor (481)
- Female (382)
- Male (377)
- Macular Degeneration (344)
- Aged (298)
- Vascular Endothelial Growth Factor A - Antagonists & Inhibitors (272)
- Diabetic Retinopathy (268)
- Tomography, Optical Coherence (242)
- Middle Aged (241)
- Angiogenesis Inhibitors - Therapeutic Use (237)
- Intravitreal Injections (226)
- Retrospective Studies (218)
- Medical Imaging (202)
- Fluorescein Angiography (200)
- Biological And Medical Sciences (180)
- Medical Sciences (179)
-
More options
Databases
Journal Title
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||